Global Melanoma Therapeutics Market Size 2024, Forecast To 2033
6 Mar, 2024
The melanoma therapeutics market size has also seen rapid growth, increasing from $3.67 billion in 2023 to $4.1 billion in 2024, marking a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to shifts in treatment guidelines, increased awareness and early detection, regulatory approvals and clinical trials, evolution of combination therapies, and advancements in surgical techniques. Looking ahead, the market is expected to see rapid growth, reaching $6.16 billion in 2028 with a CAGR of 10.7%. The forecast period's growth can be attributed to emerging treatment modalities, biomarker identification, regulatory support for innovation, advancements in personalized medicine, and enhancements in immunotherapy. Major trends in the forecast period include evolving treatment guidelines, telemedicine in oncology, patient advocacy and awareness, biomarker research, and the development of combination therapies.
Global Melanoma Therapeutics Market Key Driver
The increasing incidence of melanoma is expected to propel the growth of the melanoma therapeutics market going forward. Melanoma refers to a skin cancer that originates from melanocytes. Melanoma therapeutics are the therapies and drugs used to treat melanoma patients to alleviate cancer. Thus, the increasing incidence of melanoma boosts the sales of melanoma therapeutics. For instance, in May 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, around 57,000 melanoma deaths and 325,000 new cases of the illness were expected to occur globally in 2020. Moreover, according to IARC (International Agency for Research on Cancer) scientists, cutaneous melanoma instances will rise by more than 50% to more than 500 000 cases annually, and melanoma-related deaths will increase by more than two-thirds to almost 100,000 cases annually between 2020 and 2040. Therefore, the increasing incidence of melanoma is driving the growth of the melanoma therapeutics drug market.
Get A Free Sample Of The Global Melanoma Therapeutics Market ReportGlobal Melanoma Therapeutics Market Segments
The melanoma therapeutics market covered in this report is segmented –
1) By Drug Type: Monoclonal Antibodies, Small Molecule Inhibitors, Other Drug Types
2) By Therapy: Surgery, Radiation Therapy, Immunotherapy, Targeted Therapy, Chemotherapy
3) By Route of administration: Oral, Injectable
4) By Cancer Type: Superficial Spreading Melanoma, Nodular Melanoma, Lentigno Maligna Melanoma, Acral Lentiginous Melanoma, Amelanotic Melanoma, Other Cancer Types
5) By Diagnosis: Dermatoscopy, Entinel Lymph Node Biopsy, Blood Test, X-ray, Ultrasound, CT Scan
By Geography:The regions covered in the melanoma therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the melanoma therapeutics market in 2023. The regions covered in the melanoma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Melanoma Therapeutics Industry Players
AstraZeneca plc, Bristol-Myers Squibb Co., Eli Lilly and Company, Merck & Co. Inc., Novartis AG, Hoffmann-La Roche AG, Sanofi S.A., AB Science S.A, Amgen Inc., Daiichi Sankyo Company Limited, F. Hoffman-La Roche Ltd., Pfizer Inc., GlaxoSmithKline PLC, Bayer AG, AbbVie Inc., Johnson & Johnson Private Limited, The Bristol-Myers Squibb Company, Nektar Therapeutics, Immutep Ltd., Partner Therapeutics lnc., Idera Pharmaceuticals Inc., Oncolys BioPharma Inc., Iovance Biotherapeutics lnc., AIM ImmunoTech Inc., Infinity Pharmaceuticals lnc., Spring Bank Pharmaceuticals lnc., Incyte Corporation, Sun Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Eisai Co.Ltd., Seattle Genetics Inc., Regeneron Pharmaceuticals Inc., Bio-Rad Laboratories Inc., Illumina Inc., Myriad Genetics Inc.
Get The Full Global Melanoma Therapeutics Market Report
Melanoma Therapeutics Market Overview
Melanoma therapeutics refers to a treatment procedure used for the treatment of melanoma, a type of skin cancer that develops in the melanocytes. They work by targeting abnormal cells either by killing them directly or by preventing them from growing and multiplying.
Melanoma Therapeutics Global Market Report 2023 provides data on the global melanoma therapeutics market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The melanoma therapeutics market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.